Paul Hastings Seeks To End GenapSys Malpractice Action <https://www.law360.com/fintech/articles/2301358?nl_pk=31322029-63eb-4d40-acd3-a08313aa07ff&utm_source=newsletter&utm_medium=email&utm_campaign=fintech&utm_content=2025-02-24&read_main=1&nlsidx=1&nlaidx=6> By James Mills Paul Hastings LLP has moved for summary judgment in a malpractice action from GenapSys Inc., saying the case is barred because the genomic sequencing company failed to disclose its possible claim until after confirmation of its bankruptcy plan. 2 documents attached | Read full article » <https://www.law360.com/fintech/articles/2301358?nl_pk=31322029-63eb-4d40-acd3-a08313aa07ff&utm_source=newsletter&utm_medium=email&utm_campaign=fintech&utm_content=2025-02-24&read_more=1&nlsidx=1&nlaidx=6> | Save to favorites » <https://www.law360.com/fintech/articles/2301358?nl_pk=31322029-63eb-4d40-acd3-a08313aa07ff&utm_source=newsletter&utm_medium=email&utm_campaign=fintech&utm_content=2025-02-24&read_later=1&nlsidx=1&nlaidx=6>